In our previous study, we have concluded that administration of PI can prevent Alzheimer's disease, increase hippocampal neurogenesis, decrease microglial population, and decrease the expression of Tau and pTau after single or repeated administration (Kim et al., 2019). Here, MAPT is linked to Alzheimer disease.